CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug shows promise in early cancer trial
Disease control OngoingThis early-stage study tests a new drug called IMT-009 in people with advanced solid tumors or lymphomas that have not responded to standard treatments. The main goals are to find a safe dose and learn about side effects. About 67 participants will receive the drug intravenously,…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Immunitas Therapeutics • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New hope for transplant patients with advanced skin cancer: RP1 trial launches
Disease control OngoingThis study tests a drug called RP1, which is injected directly into skin tumors, for people who have had an organ or stem cell transplant and now have advanced skin cancer. The goal is to see if RP1 can shrink tumors safely without harming the transplanted organ. About 69 partici…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Sweat before shots: exercise may boost cancer immunotherapy
Disease control OngoingThis early-phase study tests whether 30 minutes of moderate exercise (like cycling or walking) right before standard immunotherapy can improve how well the treatment works against certain skin cancers. About 22 adults with melanoma, squamous cell carcinoma, or Merkel cell carcino…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Flash of hope: new Ultra-Fast radiation tested for skin cancer
Disease control OngoingThis study tests a new type of radiation therapy called FLASH, which delivers treatment in a fraction of a second, against standard radiotherapy for people with localized skin cancer (basal cell or squamous cell carcinoma). The goal is to see if FLASH causes fewer severe skin sid…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Promising drug may keep aggressive skin cancer at bay after surgery and radiation
Disease control OngoingThis study tests whether adding the drug cemiplimab after standard surgery and radiation can help prevent high-risk cutaneous squamous cell carcinoma from returning. About 415 adults who have completed surgery and radiation for this aggressive skin cancer will receive either cemi…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New pill shows promise for tough skin cancer
Disease control OngoingThis study tests an experimental drug called INCB099280 in 63 adults with advanced squamous cell skin cancer that cannot be removed by surgery or radiation. The main goals are to see if the drug shrinks tumors and to check for side effects. Participants take the drug by mouth and…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New combo therapy aims to turn tumors against themselves in advanced cancer patients
Disease control OngoingThis early-phase study tests whether a mix of drugs and targeted radiation can help the immune system recognize and attack hard-to-treat solid tumors. About 14 adults with advanced melanoma, breast cancer, or other solid cancers that cannot be surgically removed will receive inje…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug shows promise before skin cancer surgery
Disease control OngoingThis early-stage study tests whether giving the drug cemiplimab before surgery is safe for people with Merkel cell carcinoma or cutaneous squamous cell carcinoma. About 36 participants will receive the drug and then have their tumors removed. Researchers will track side effects a…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Walk before treatment: could a short workout boost cancer therapy?
Symptom relief OngoingThis small pilot study tests whether a short exercise session on the same day as immunotherapy can help patients with skin cancers like melanoma. Twelve adults scheduled for their first immunotherapy will walk for 20-30 minutes before treatment. The goal is to see if this is feas…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated May 17, 2026 03:11 UTC